Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour

被引:76
作者
Hanks, Sandra [1 ]
Perdeaux, Elizabeth R. [1 ]
Seal, Sheila [1 ]
Ruark, Elise [1 ]
Mahamdallie, Shazia S. [1 ]
Murray, Anne [1 ]
Ramsay, Emma [1 ]
Duarte, Silvana Del Vecchio [1 ]
Zachariou, Anna [1 ]
de Souza, Bianca [1 ,2 ]
Warren-Perry, Margaret [1 ]
Elliott, Anna [1 ]
Davidson, Alan [3 ]
Price, Helen [4 ]
Stiller, Charles [5 ]
Pritchard-Jones, Kathy [6 ]
Rahman, Nazneen [1 ,2 ]
机构
[1] Canc Res Inst, Div Genet & Epidemiol, London SM2 5NG, England
[2] Royal Marsden Hosp, NHS Fdn Trust, Canc Genet Unit, London SM2 5PT, England
[3] Univ Cape Town, Red Cross Childrens Hosp, Dept Paediat Haematol Oncol, ZA-7700 Cape Town, South Africa
[4] Great Western Hosp, Dept Paediat, Swindon SN3 6BB, Wilts, England
[5] Univ Oxford, Childhood Canc Res Grp, Oxford OX1 2JD, England
[6] UCL, Inst Child Hlth, Mol Haematol & Canc Biol Unit, London WC1E 6BT, England
基金
英国惠康基金;
关键词
TRANSCRIPTION; FWT1;
D O I
10.1038/ncomms5398
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Wilms tumour is a childhood kidney cancer. Here we identify inactivating CTR9 mutations in 3 of 35 Wilms tumour families, through exome and Sanger sequencing. By contrast, no similar mutations are present in 1,000 population controls (P<0.0001). Each mutation segregates with Wilms tumour in the family and a second mutational event is present in available tumours. CTR9 is a key component of the polymerase-associated factor 1 complex which has multiple roles in RNA polymerase II regulation and is implicated in embryonic organogenesis and maintenance of embryonic stem cell pluripotency. These data establish CTR9 as a Wilms tumour predisposition gene and suggest it acts as a tumour suppressor gene.
引用
收藏
页数:7
相关论文
共 16 条
[1]   Paf1 complex homologues are required for Notch-regulated transcription during somite segmentation [J].
Akanuma, Takashi ;
Koshida, Sumito ;
Kawamura, Akinori ;
Kishimoto, Yasuyuki ;
Takada, Shinji .
EMBO REPORTS, 2007, 8 (09) :858-863
[2]   Versatile TPR domains accommodate different modes of target protein recognition and function [J].
Allan, Rudi Kenneth ;
Ratajczak, Thomas .
CELL STRESS & CHAPERONES, 2011, 16 (04) :353-367
[3]   HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome [J].
Carpten, JD ;
Robbins, CM ;
Villablanca, A ;
Forsberg, L ;
Presciuttini, S ;
Bailey-Wilson, J ;
Simonds, WF ;
Gillanders, EM ;
Kennedy, AM ;
Chen, JD ;
Agarwal, SK ;
Sood, R ;
Jones, MP ;
Moses, TY ;
Haven, C ;
Petillo, D ;
Leotlela, PD ;
Harding, B ;
Cameron, D ;
Pannett, AA ;
Höög, A ;
Heath, H ;
James-Newton, LA ;
Robinson, B ;
Zarbo, RJ ;
Cavaco, BM ;
Wassif, W ;
Perrier, ND ;
Rosen, IB ;
Kristoffersson, U ;
Turnpenny, PD ;
Farnebo, LO ;
Besser, GM ;
Jackson, CE ;
Morreau, H ;
Trent, JM ;
Thakker, RV ;
Marx, SJ ;
Teh, BT ;
Larsson, C ;
Hobbs, MR .
NATURE GENETICS, 2002, 32 (04) :676-680
[4]   A Genome-Scale RNAi Screen for Oct4 Modulators Defines a Role of the Paf1 Complex for Embryonic Stem Cell Identity [J].
Ding, Li ;
Paszkowski-Rogacz, Maciej ;
Nitzsche, Anja ;
Slabicki, Mikolaj Michal ;
Heninger, Anne-Kristin ;
de Vries, Ingrid ;
Kittler, Ralf ;
Junqueira, Magno ;
Shevchenko, Andrej ;
Schulz, Herbert ;
Hubner, Norbert ;
Doss, Michael Xavier ;
Sachinidis, Agapios ;
Hescheler, Juergen ;
Iacone, Roberto ;
Anastassiadis, Konstantinos ;
Stewart, A. Francis ;
Pisabarro, M. Teresa ;
Caldarelli, Antonio ;
Poser, Ina ;
Theis, Mirko ;
Buchholz, Frank .
CELL STEM CELL, 2009, 4 (05) :403-415
[5]   The Paf1 complex: Platform or player in RNA polymerase II transcription? [J].
Jaehning, Judith A. .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2010, 1799 (5-6) :379-388
[6]   Stampy: A statistical algorithm for sensitive and fast mapping of Illumina sequence reads [J].
Lunter, Gerton ;
Goodson, Martin .
GENOME RESEARCH, 2011, 21 (06) :936-939
[7]  
McDonald JM, 1998, CANCER RES, V58, P1387
[8]   Ctr9, Rtf1, and Leo1 are components of the Paf1/RNA polymerase II complex [J].
Mueller, CL ;
Jaehning, JA .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (07) :1971-1980
[9]   Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial [J].
Pritchard-Jones, K. ;
Moroz, V. ;
Vujanic, G. ;
Powis, M. ;
Walker, J. ;
Messahel, B. ;
Hobson, R. ;
Levitt, G. ;
Kelsey, A. ;
Mitchell, C. .
ANNALS OF ONCOLOGY, 2012, 23 (09) :2457-2463
[10]   Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21 [J].
Rahman, N ;
Arbour, L ;
Tonin, P ;
Renshaw, J ;
Pelletier, J ;
Baruchel, S ;
PritchardJones, K ;
Stratton, MR ;
Narod, SA .
NATURE GENETICS, 1996, 13 (04) :461-463